About IgA nephropathy
Obis autem facitempore ped ut imendip itaestrum ligent eatenihil inciis venis rehent eum nis vendesc illuptius ma susdaeprerum il et assinverum aligendis animin cuptas volupta turemqui oditatquame perio. Ibusa id enet harchicitios eosapid quatur? Quis aut ditas di delici intur molupta volupta si comnisc ientem sequo dit, to volent voluptatio eossintiae pre abore doluptustio. Neque ad quasiti ossitia si blaborpor aut doluptati omnimaxim accab int.
Inveniet errumque consequis nulliti delendis maio que plit qui volest, od que volorestio.
Ut ommodisit, optatiur? Quis et ellia dolupta perum ilias aceat moditatur?
The nephrologists take the floor
(draft) KDIGO 2024 clinical practice guideline
for the management of immunoglobulin a nephropathy (igan) and immunoglobulin a vasculitis (igav)
This is a draft document shared for public review and feedback only. The content of this draft will change based on the feedback received, and should not be used for any other purpose beyond its original intent.
A KDIGO virtual event covering ANCA-Associated Vasculitis (AAV), Complement-Mediated Kidney Disease, IgA Nephropathy (IgAN) and Lupus Nephritis (LN)
Overview
KDIGO GEMs (Guideline Education Meetings) is a new programme offering virtual education on the latest KDIGO Guidelines and evidence-based updates. These interactive events are designed to empower healthcare professionals with the knowledge and tools needed to understand and apply KDIGO recommendations in real-world clinical practice.
By combining cutting-edge guidance with practical insights, KDIGO GEMs provide an engaging platform to enhance clinician expertise, improve patient outcomes and advance global best practices in kidney disease care.
KDIGO is launching our first-ever guideline implementation programme with a focus on glomerular diseases, including topics such as Lupus Nephritis, ANCA-associated Vasculitis, IgA Nephropathy, and Complement-Mediated Kidney Disease. This innovative programme will provide a comprehensive understanding of how to apply KDIGO's evidence-based recommendations and practice points most effectively.
The presentations will also feature live Q&A sessions for each topic module where the audience can interact with key opinion leaders about the latest state-of-the-art, challenging clinical scenarios and optimal management approaches for the complex patient.
Watch here the recording of the KDIGO Guideline Education Meeting on Glomerular Diseases
